---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-059697"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2026-09-01T10:47:19+00:00"
generated_at: "2026-09-01T10:50:04.123750+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medtronic Q1 FY27 revenue up 13.7% to $9.76B; raises FY27 guidance

## Summary
- Q1 revenue $9.756B, +13.7% reported and organic; GAAP EPS $1.14, non-GAAP EPS $1.45.
- Raises FY27 organic revenue growth to 7.25-7.75% (from 6.75-7.25%) and non-GAAP EPS to $5.94-6.00.
- Cardiovascular +18.9% organic, Neuroscience +9.3%, Medical Surgical +10.2%, Diabetes +14.9%.
- Extra fiscal week added ~$570M to Q1 organic growth; completed acquisitions of Scientia Vascular and SPR Therapeutics.
- Announced strategic investments in Pi-Cardia and Cornerstone Robotics; FDA clearance for Touch Surgery Aide.

## SEC filing metadata
- accession: 0001628280-26-059697
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2026-09-01T10:47:19+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/0001628280-26-059697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/mdt-20260901.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-059697
- JSON: https://secwatch.observer/filing/0001628280-26-059697.json
- Plain text: https://secwatch.observer/filing/0001628280-26-059697.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.